Advertisement

International Journal of Hematology

, Volume 79, Issue 5, pp 505–506 | Cite as

May-Hegglin Anomaly Developing Myelodysplasia and Acute Myeloid Leukemia

  • Naohito Fujishima
  • Makoto Hirokawa
  • Hiroyasu Ishikawa
  • Masumi Fujishima
  • Masaaki Kume
  • Ikuo Miura
  • Ken-ichi Sawada
Letter to the Editor

Keywords

Acute Myeloid Leukemia International Prognostic Scoring System Menatetrenone Giant Platelet Nonmuscle Myosin Heavy Chain 

References

  1. 1.
    Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–2088.Google Scholar
  2. 2.
    Takami A, Asakura H, Nakao S. Menatetrenone, a vitamin K2 analog, ameliorates cytopenia in patients with refractory anemia of myelodysplastic syndrome. Ann Hematol. 2002;81:16–19.CrossRefGoogle Scholar
  3. 3.
    Abe Y, Muta K, Hirase N, et al. Vitamin K2 therapy for myelodysplastic syndrome [in Japanese]. Rinsho Ketsueki. 2002;43:117–121.Google Scholar
  4. 4.
    Tsurusawa M, Mamiya S. What is the difference between May-Hegglin anomaly and Sebastian platelet syndrome? Int J Hematol. 2000;71:400–401.Google Scholar
  5. 5.
    Kunishima S, Matsushita T, Kojima T, et al. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest. 2003;83:115–122.CrossRefGoogle Scholar
  6. 6.
    Seri M, Pecci A, Di Bari F, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine. 2003;82:203–215.Google Scholar
  7. 7.
    Seri M, Cusano R, Gangarossa S, et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Hegglin/Fechtner Syndrome Consortium. Nat Genet. 2000;26:103–105.CrossRefPubMedGoogle Scholar
  8. 8.
    Kelley MJ, Jawien W, Ortel TL, Korczak JF. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet. 2000;26:106–108.CrossRefPubMedGoogle Scholar
  9. 9.
    Toothaker LE, Gonzalez DA, Tung N, et al. Cellular myosin heavy chain in human leukocytes: isolation of 5′ cDNA clones, characterization of the protein, chromosomal localization, and upregulation during myeloid differentiation. Blood. 1991;78:1826–1833.PubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2004

Authors and Affiliations

  • Naohito Fujishima
    • 1
  • Makoto Hirokawa
    • 1
  • Hiroyasu Ishikawa
    • 1
  • Masumi Fujishima
    • 1
  • Masaaki Kume
    • 1
  • Ikuo Miura
    • 1
  • Ken-ichi Sawada
    • 1
  1. 1.Department of Internal Medicine IIIAkita University School of MedicineAkitaJapan

Personalised recommendations